Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...

Celebrity chef Gordon Ramsay has ruled out changing the menus at his restaurants to accommodate customers who use weight-loss ...

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

IT’S hard not to notice the amount of male celebrities who have stepped out sporting a much slimmer frame and chiselled ...

Across the reviews, tirzepatide, semaglutide, and liraglutide all produced considerable ... Liraglutide, given as a daily injection, produced a modest average weight loss of approximately 4–5%, as ...

For decades, bodybuilders and biohackers quietly experimented with peptides in underground forums and gym locker rooms. Then ...

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly ...

CAM2056 showed weight and A1c reductions comparable to or exceeding those seen for weekly semaglutide (Wegovy®) Results include a 9.3% weight reduction ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...